Lichen planus following <scp>SARS‐CoV</scp>‐2 infection and vaccination? A systematic review

Feschuk, Aileen M.; Green, Maxwell; Kashetsky, Nadia; Maibach, Howard I.

doi:10.1111/ijd.16480

Cited by 2 publications

(3 citation statements)

References 3 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since the beginning of the Covid-19 pandemic, the literature has been flooded by case reports of patients developing autoimmune and immune-mediated diseases concomitantly or immediately following SARS-CoV-2 infection. New onset of LP following SARS-CoV-2 respiratory infection or vaccinations have also been reported ( 3 ), similarly to other previously described association with potential immunological disturbers, such as HCV infection or HBV, HCV and influenza vaccines ( 4 – 6 ). On the other hand, only very few cases have been so far reported of patients affected by immune-mediated disorders who have clinically improved or fully recovered from their condition after a Covid-19 respiratory infection.…”

Section: Introductionsupporting

confidence: 75%

Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection

et al. 2023

View full text Add to dashboard Cite

It is well known that viral infections play a relevant role in inducing or protecting from autoimmune diseases, thus representing a major environmental factor in the disruption of the immune system in genetically susceptible individuals. Since the beginning of the Covid-19 pandemic a great number of clinical and epidemiological studies have demonstrated that SARS-CoV-2 infection is no exception to the rule by interfering on many different levels in the normal functioning of our immune system. Even though a growing number of case series and case reports has been cited in the literature linking the infection to the new onset of autoimmune diseases, to date very little has been reported concerning a possible correlation between the virus and the clinical resolution of any kind of autoimmune pathology. Here we describe an interesting case of abrupt and unexpected resolution of Lichen planus pemphigoides mucocutaneous lesions in a fully vaccinated patient after a mildly symptomatic SARS-CoV-2 respiratory infection and we speculate on the possible underlying mechanisms correlating the two events.

show abstract

Section: Introductionsupporting

confidence: 75%

Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In contrast to this registry, the literature describes chilblain‐like lesions, erythema multiforme, and urticaria as the most common skin features of the COVID‐19 virus 42,43 . To the best of our knowledge, lichen planus following COVID‐19 vaccination has only been reported in the adult population 44 . The registry reveals the first case of lichen planus post vaccination in the pediatric population.…”

Section: Discussionmentioning

confidence: 91%

“…42,43 To the best of our knowledge, lichen planus following COVID-19 vaccination has only been reported in the adult population. 44 The registry reveals the first case of lichen planus post vaccination in the pediatric population.…”

Section: Discussionmentioning

confidence: 99%

Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry

Chrabieh,

Haddad,

Salameh

et al. 2023

Int J Dermatology

View full text Add to dashboard Cite

BackgroundA number of cutaneous manifestations and adverse cutaneous reactions have been associated with COVID‐19 infection and vaccine.ObjectivesA Lebanese national registry was established to characterize the dermatologic manifestations and adverse cutaneous reactions associated with COVID‐19 infection and vaccination in a sample of the Lebanese population.MethodsAn observational cross‐sectional study was conducted via a web‐based clinical form distributed to physicians wishing to report their cases from May 2021 till May 2022.ResultsIn total, 142 patients were entered in the registry, of which 133 were adults and nine were pediatric patients. The main dermatological manifestations reported with COVID‐19 infection in the adult group were urticaria (32.9%), telogen effluvium (21.4%), morbilliform (10%), and papulosquamous (8.6%) eruptions. Urticaria was the most common adverse cutaneous reaction to the vaccine (33%). Interestingly, herpes zoster was triggered in 12 patients post vaccination in our series with this finding more frequently seen in patients above the age of 41 (P = 0.013). In the pediatric group, the most reported dermatological findings associated with COVID‐19 infection were malar erythema (25%) and telogen effluvium (25%). One 16‐year‐old patient developed lichen planus after one dose of a COVID‐19 vaccine. No deaths were reported in both age groups.ConclusionThis Lebanese registry adds more robust evidence that clinical manifestations of the COVID‐19 virus and vaccine are diverse. More studies are necessary to establish the pathophysiology of these dermatological findings in the context of COVID‐19 infection and vaccination.

show abstract

Lichen planus following SARS‐CoV‐2 infection and vaccination? A systematic review

Cited by 2 publications

References 3 publications

Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection

Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection

Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry

Contact Info

Product

Resources

About